{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:03Z","timestamp":1792782783165,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tel Aviv University","id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate whether oral glucose tolerance test (OGTT)-derived metabolic abnormalities and maternal characteristics predict metformin failure in women with gestational diabetes mellitus (GDM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included women with singleton pregnancies and gestational diabetes mellitus treated with metformin at a tertiary center (2018\u20132023). Gestational diabetes mellitus was diagnosed using the American Diabetes Association (ADA) two-step approach, consisting of an initial 50-g glucose challenge screening test followed, when abnormal, by a diagnostic 100-g, 3-h oral glucose tolerance test performed under fasting conditions and interpreted according to Carpenter-Coustan criteria (fasting\u2009\u2265\u200995\u00a0mg\/dL, 1-h\u2009\u2265\u2009180\u00a0mg\/dL, 2-h\u2009\u2265\u2009155\u00a0mg\/dL, and 3-h\u2009\u2265\u2009140\u00a0mg\/dL). Routine screening was generally performed between 24 and 28\u00a0weeks\u2019 gestation, with earlier testing in high-risk women when clinically indicated. Of 431 women who initiated metformin, 6 discontinued due to adverse effects, leaving 425 for analysis. Impaired fasting glucose (IFG) was defined as fasting OGTT\u2009\u2265\u200995\u00a0mg\/dL. The primary outcome was metformin failure, defined as subsequent insulin initiation. Multivariable logistic regression included prespecified OGTT-derived phenotypes rather than simultaneous inclusion of all continuous OGTT variables in order to reduce multicollinearity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 425 women, 114 (26.8%) required insulin. These women had higher glucose values at all OGTT time points and a higher prevalence of IFG (41.2% vs 26.4%, p\u2009=\u20090.005). An abnormal 180-min value was also more frequent (21.1% vs 5.1%, p\u2009&lt;\u20090.001). The number of abnormal OGTT values did not differ significantly between groups and was not independently associated with metformin failure. In multivariable analysis, IFG (aOR 1.96, 95% CI 1.25\u20133.07) and an abnormal 180-min OGTT value (aOR 4.92, 95% CI 2.50\u20139.66) remained independently associated with metformin failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IFG and an elevated 180-min OGTT value may identify women with GDM at higher risk for treatment escalation. These findings should not be interpreted as direct indications for insulin initiation but rather as potential markers of increased risk for metformin failure requiring closer glycemic surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08528-7","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:34:59Z","timestamp":1784648099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impaired fasting glucose and elevated 180-minute OGTT values predict metformin failure in gestational diabetes mellitus: a retrospective cohort study"],"prefix":"10.1007","volume":"313","author":[{"given":"Sivan","family":"Farladansky-Gershnabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Baram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Saffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilil","family":"Mishani-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Or","family":"Eliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Biron-Shental","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Ravid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"8528_CR1","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin M, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358:2003\u20132015","journal-title":"N Engl J Med"},{"key":"8528_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/dc16-2307","volume":"40","author":"Z Nachum","year":"2017","unstructured":"Nachum Z, Zafran N, Salim R et al (2017) Glyburide versus metformin and their combination for gestational diabetes mellitus. Diabetes Care 40:332\u2013337","journal-title":"Diabetes Care"},{"key":"8528_CR3","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 190. Gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49\u2013e64.","DOI":"10.1097\/AOG.0000000000002501"},{"key":"8528_CR4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger BE, Gabbe SG, Persson B et al (2010) IADPSG recommendations. Diabetes Care 33:676\u2013682","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"8528_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc24-SINT","volume":"47","author":"American Diabetes Association","year":"2024","unstructured":"American Diabetes Association (2024) Standards of medical care in diabetes\u20142024. Diabetes Care 47(Suppl 1):S1\u2013S291","journal-title":"Diabetes Care"},{"key":"8528_CR6","first-page":"1","volume":"37","author":"P Damm","year":"2016","unstructured":"Damm P (2016) Gestational diabetes mellitus and long-term consequences. Endocr Rev 37:1\u201327","journal-title":"Endocr Rev"},{"key":"8528_CR7","first-page":"262.e1","volume":"207","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The HAPO Study. Am J Obstet Gynecol 207:262.e1-262.e7","journal-title":"Am J Obstet Gynecol"},{"key":"8528_CR8","first-page":"2247","volume":"379","author":"WL Lowe Jr","year":"2018","unstructured":"Lowe WL Jr, Scholtens DM, Lowe LP et al (2018) Maternal glucose and childhood adiposity. N Engl J Med 379:2247\u20132257","journal-title":"N Engl J Med"},{"key":"8528_CR9","first-page":"1055","volume":"28","author":"TA Buchanan","year":"2005","unstructured":"Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. Diabetes Care 28:1055\u20131066","journal-title":"Diabetes Care"},{"key":"8528_CR10","first-page":"1957","volume":"56","author":"LA Barbour","year":"2007","unstructured":"Barbour LA, McCurdy CE, Hernandez TL et al (2007) Cellular mechanisms for insulin resistance in pregnancy. Diabetes 56:1957\u20131964","journal-title":"Diabetes"},{"key":"8528_CR11","first-page":"450","volume":"7","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, Catalano P, Zhang C et al (2019) Gestational diabetes mellitus. Lancet Diabetes Endocrinol 7:450\u2013461","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8528_CR12","first-page":"2432","volume":"34","author":"R Retnakaran","year":"2011","unstructured":"Retnakaran R, Qi Y, Connelly PW et al (2011) Progression to diabetes after gestational diabetes. Diabetes Care 34:2432\u20132437","journal-title":"Diabetes Care"},{"key":"8528_CR13","doi-asserted-by":"crossref","first-page":"e1172","DOI":"10.1210\/clinem\/dgaa831","volume":"106","author":"K Benhalima","year":"2021","unstructured":"Benhalima K, Van Crombrugge P, Moyson C et al (2021) Subtypes of gestational diabetes mellitus. J Clin Endocrinol Metab 106:e1172\u2013e1184","journal-title":"J Clin Endocrinol Metab"},{"key":"8528_CR14","first-page":"1358","volume":"44","author":"CE Powe","year":"2021","unstructured":"Powe CE, Hivert MF, Udler MS (2021) Defining metabolic phenotypes of gestational diabetes. Diabetes Care 44:1358\u20131366","journal-title":"Diabetes Care"},{"key":"8528_CR15","volume":"11","author":"VB Silva","year":"2022","unstructured":"Silva VB, Fonseca L, Pereira MT et al (2022) Predictors of metformin monotherapy failure in gestational diabetes. Endocr Connect 11:e210540","journal-title":"Endocr Connect"},{"key":"8528_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s43856-023-00371-0","volume":"3","author":"JL Benham","year":"2023","unstructured":"Benham JL, Gingras V, McLennan NM et al (2023) Precision gestational diabetes treatment. Commun Med 3:135","journal-title":"Commun Med"},{"key":"8528_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ajo.12018","volume":"53","author":"A Corbould","year":"2013","unstructured":"Corbould A, Swinton F, Radford A et al (2013) Fasting glucose predicts response to metformin in gestational diabetes. Aust N Z J Obstet Gynaecol 53:125\u2013129","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"8528_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.dsx.2018.01.003","volume":"12","author":"MO Khin","year":"2018","unstructured":"Khin MO, Gates S, Saravanan P (2018) Predictors of metformin failure in gestational diabetes. Diabetes Metab Syndr 12:405\u2013410","journal-title":"Diabetes Metab Syndr"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08528-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08528-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08528-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:37:23Z","timestamp":1792125443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08528-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8528"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08528-7","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Meir Medical Center.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived due to the retrospective design.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"293"}}